IL17A and relapsing-remitting multiple sclerosis: Overexpressed IRF4 in naive CD4+ T cells derived from relapsing remitting multiple sclerosis patients significantly increased their ability to secrete IL-17A, IL-17F, IL-21, and IL-22 [28].